Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Hypertension (Dallas, Tex. : 1979)|April 18, 2012
Low-dose spironolactone prevents apoptosis repressor with caspase recruitment domain degradation during myocardial infarctionThi Yen Loan Le, Mahidi Mardini, Viive M Howell, et al.
Frontiers in Oncology|April 15, 2021
Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in GlioblastomaKelly J McKelvey, Erica B Wilson, Susan Short, et al.
Scientific Reports|August 22, 2014
Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesotheliomaAmanda L Hudson, Chris Weir, Elizabeth Moon, et al.
Proteomics. Clinical Applications|March 11, 2015
Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelinesLucy Jankova, Owen F Dent, Mark P Molloy, et al.
Asia-Pacific Journal of Clinical Oncology|April 21, 2018
Pattern of care and survival of anaplastic lymphoma kinase rearranged non-small cell lung cancer (ALK+ NSCLC) in an Australian Metropolitan Tertiary Referral Centre: A retrospective cohort analysisMalinda Itchins, Sarah A Hayes, Anthony J Gill, et al.
Radiation Oncology (London, England)|January 25, 2022
Differential effects of radiation fractionation regimens on glioblastomaKelly J McKelvey, Amanda L Hudson, Heather Donaghy, et al.
Human Molecular Genetics|July 28, 2007
Evidence for a direct role of the disease modifier SCNM1 in splicingViive M Howell, Julie M Jones, Sarah K Bergren, et al.
BMC Cancer|January 1, 2013
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancerCasina W S Kan, Michael A Hahn, Gregory B Gard, et al.
Cancers|August 12, 2022
An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of MesotheliomaEmily K Colvin, Amanda L Hudson, Lyndsey L Anderson, et al.
Frontiers in Oncology|February 4, 2020
Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for CancerKelly J McKelvey, Amanda L Hudson, Ramyashree Prasanna Kumar, et al.
Pageof 6